Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1478 total)
-
Creator: Madad, Syra, and Vikram Mukherjee.
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2021-06-23
Description: As the world focuses on combatting COVID-19, we are reminded once again that dozens of outbreaks of other infection diseases continue to occur. Many of these diseases are endemic like Ebola virus disease (EVD) in the Democratic Republic of the Congo…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: Tolf, Eleanor, and Syra Madad.
Subject: Training and Exercises
Item Type: Publication
Date Last Updated: 2021-06-18
Description: The purpose of this evaluation was to determine the effect of intensive, interactive training on hospital workers’ preparedness for special pathogen cases by utilizing the Frontline Facility Special Pathogens Training Course created by the Systemwide… -
Creator: the BATS Consortium
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-06-16
Description: Evidence is urgently needed to support treatment decisions for children with multisystem inflammatory syndrome (MIS-C) associated with severe acute respiratory syndrome coronavirus 2.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: the Overcoming COVID-19 Investigators
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-06-16
Description: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. -
Creator: Guetl, Katharina, Thomas Gary, Reinhard B. Raggam, Johannes Schmid, Albert Wölfler, and Marianne Brodmann.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-06-11
Description: A 50-year-old woman attended our emergency department with a 3-day history of severe back pain and a severe headache. 10 days earlier she had received the first dose of vaccine against SARS-CoV-2—ChAdOx1 nCoV-19 (AstraZeneca). The patient had no… -
Creator: the ENSEMBLE Study Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-06-10
Description: The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation. -
Creator: Peart Akindele, Nadine, Theodore Kouo, Andrew H. Karaba, Oren Gordon, Katherine Z. J. Fenstermacher, Jeanette Beaudry, Jessica H. Rubens, Christine C. Atik, Weiqiang Zhou, Hongkai Ji, Xueting Tao, Dhananjay Vaidya, Heba Mostafa, Patrizio Caturegli,…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-05-24
Description: Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe clinical phenotype of SARS-CoV-2 infection that remains poorly understood. -
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2021-05-21
Description: Webinar slides attached.Objectives: Discuss the epidemiology, pathology, symptoms, and diagnosis of Long COVID Describe options for treatment support for Long COVID Explain how the members of the team can provide psychological support for Long COVID… -
Creator: Emory
Subject: Infection Control
Item Type: Protocol
Date Last Updated: 2021-05-21
Description: SCOPE:The SCDU follows a defined set of protocols for activation of the Unit. Because the SCDU must be prepared for a wide range of infectious agents, plans exist to respond as appropriate based on the agent and clinical presentation of the patient.… -
Creator: Daniel, William, Marc Nivet, John Warner, and Daniel K. Podolsky.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-05-20
Description: Emergency use authorizations for two messenger RNA (mRNA) vaccines — the BNT162b2 vaccine (Pfizer–BioNTech) and the mRNA-1273 vaccine (Moderna) — marked important milestones in efforts to respond to the coronavirus disease 2019 (Covid-19) pandemic.…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.